Prostate-specific antigen doubling time and response to cabazitaxel in a hormone-resistant metastatic prostate cancer patient
Prostate-specific antigen doubling time and response to cabazitaxel in a hormone-resistant metastatic prostate cancer patient作者机构:Hematology-Oncology DepartmentFaculty of MedicineSaint-Joseph University
出 版 物:《The Journal of Biomedical Research》 (生物医学研究杂志(英文版))
年 卷 期:2015年第29卷第5期
页 面:420-422页
核心收录:
学科分类:0710[理学-生物学] 1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题:prostate-specific antigen doubling time prostate cancer cabazitaxel docetaxel
摘 要:We report a case of metastatic castration-resistant prostate cancer, who received prior treatment with docetaxel and was then given cabazitaxel as salvage therapy. The patient was monitored by prostate-specific antigen doubling time and prostate-specific antigen absolute value. The prostate-specific antigen doubling time was found to be a good response predictor in the patient.